| Literature DB >> 28556466 |
Kie Kasuga1,2, Yasutake Katoh3, Keisuke Nagase2, Kazuhiko Igarashi3,4.
Abstract
Ultimately, cell biology seeks to define molecular mechanisms underlying cellular functions. However, heterogeneity within cell populations must be considered for optimal assay design and data interpretation. Although single-cell analyses are desirable for addressing this issue, practical considerations, including assay sensitivity, limit their broad application. Therefore, omics studies on small numbers of cells in defined subpopulations represent a viable alternative for elucidating cell functions at the molecular level. MS-based proteomics allows in-depth proteome exploration, although analyses of small numbers of cells have not been pursued due to loss during the multistep procedure involved. Thus, optimization of the proteomics workflow to facilitate the analysis of rare cells would be useful. Here, we report a microproteomics workflow for limited numbers of immune cells using non-damaging, microfluidic chip-based cell sorting and MS-based proteomics. Samples of 1000 or 100 THP-1 cells were sorted, and after enzymatic digestion, peptide mixtures were subjected to nano-LC-MS analysis. We achieved reasonable proteome coverage from as few as 100-sorted cells, and the data obtained from 1000-sorted cells were as comprehensive as those obtained using 1 μg of whole cell lysate. With further refinement, our approach could be useful for studying cell subpopulations or limited samples, such as clinical specimens.Entities:
Keywords: Cell sorting; Mass spectrometry; Microproteomics; Monocytes; Sample preparation
Mesh:
Substances:
Year: 2017 PMID: 28556466 PMCID: PMC5600086 DOI: 10.1002/pmic.201600420
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 3.984
Scheme 1Overview of the workflow in this study. First, 100 or 1000 sorted THP‐1 cells were collected in a BSA‐coated tube or a hydrophilic‐coated tube, and following each sample processing procedure, protein profiling was performed. Five Groups were prepared: Group 1: 1000 cells in a BSA‐coated tube digested with medium; Group 2: 1000 cells in a BSA‐coated tube with the medium removed; Group 3: 1000 cells in a hydrophilic‐coated tube with the medium removed; Group 4: 100 cells in a BSA‐coated tube digested with medium; Group 5: 100 cells in a BSA‐coated tube with the medium removed. Schematic diagram of cell sorting in the microfluidic‐based cell sorter and 1000‐sorted cells gated by HLA‐DR+. The original diagram was kindly provided by On‐chip Biotechnologies Co., Ltd.
Figure 1Microproteome profiling and characteristics (A) Proteins identified from 1000‐sorted cells: Group 1: BSA‐coated tube digested with medium; Group 2: BSA‐coated tube with the medium removed; Group 3: hydrophilic‐coated tube with the medium removed (B) Proteins from 100‐sorted cells: Group 4: BSA‐coated tube digested with medium; Group 5: BSA‐coated tube with the medium removed. w. CENTRF: with centrifugation (C) Miscleaved peptide sites under each condition. Some error bars are invisible because of low variability. Unpaired T‐test: ǂ, Group 1 vs. Group 2, p< 0.05, #, Group 1 vs. Group 3, p< 0.01 (D) Distribution of the peptide GRAVY score from 1000‐sorted THP‐1 cells in BSA‐coated or hydrophilic‐coated tubes. (N = 3).
Figure 2Proteome profiling in micro‐ and conventional proteomics (A) Venn diagrams comparing the proteins or peptides identified from 1000‐sorted cells, 100‐sorted cells or bulk cell lysate. (Groups 1, 4 and bulk cell lysate) (B) GO analysis of cellular components for the proteins identified from bulk cell lysate (open), 1000‐sorted cells (Group 1, gray) and 100‐sorted cells (Group 4, striped). The results are shown as the frequency (%) of the top ten GO terms in each group.